ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $930,000 | +25.7% | 13,791 | +27.6% | 0.00% | +100.0% |
| Q2 2023 | $740,000 | +100.0% | 10,808 | +57.7% | 0.00% | 0.0% |
| Q1 2023 | $370,000 | -15.1% | 6,854 | -4.0% | 0.00% | 0.0% |
| Q4 2022 | $436,000 | +105.7% | 7,140 | +89.1% | 0.00% | 0.0% |
| Q2 2022 | $212,000 | -14.5% | 3,775 | +8.0% | 0.00% | 0.0% |
| Q1 2022 | $248,000 | +12.7% | 3,495 | +3.8% | 0.00% | – |
| Q4 2021 | $220,000 | -24.1% | 3,367 | -12.7% | 0.00% | -100.0% |
| Q3 2021 | $290,000 | +14.6% | 3,857 | +18.6% | 0.00% | 0.0% |
| Q2 2021 | $253,000 | -10.3% | 3,252 | -5.6% | 0.00% | 0.0% |
| Q1 2021 | $282,000 | -4.1% | 3,445 | -3.7% | 0.00% | 0.0% |
| Q4 2020 | $294,000 | +40.0% | 3,576 | +8.8% | 0.00% | 0.0% |
| Q1 2020 | $210,000 | +4.5% | 3,286 | +12.8% | 0.00% | 0.0% |
| Q4 2019 | $201,000 | -54.2% | 2,912 | -61.1% | 0.00% | -66.7% |
| Q1 2019 | $439,000 | +1.9% | 7,479 | +6.4% | 0.00% | 0.0% |
| Q4 2018 | $431,000 | -8.1% | 7,026 | +16.2% | 0.00% | 0.0% |
| Q3 2018 | $469,000 | – | 6,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |